BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 10677921)

  • 1. Influence of morning or evening administration on absorption of theophylline.
    Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on the effect of food on the absorption of theophylline.
    Su YM; Cheng TP; Wen CY
    J Chin Med Assoc; 2003 Dec; 66(12):715-21. PubMed ID: 15015820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of enteral feedings on sustained-release theophylline absorption.
    Plezia PM; Thornley SM; Kramer TH; Armstrong EP
    Pharmacotherapy; 1990; 10(5):356-61. PubMed ID: 2122422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of theophylline chronokinetics for asthmatic children.
    Smolensky MH; Scott PH; McGovern JP
    Prog Clin Biol Res; 1987; 227B():259-70. PubMed ID: 3628336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics and chronotherapy of delayed action theophylline (Euphyllin CR)].
    Vondra V; Spicák V; Trnavská Z; Reisová M; Pohunek P; Tomíska F
    Cas Lek Cesk; 1989 May; 128(19):595-8. PubMed ID: 2743384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronopharmacokinetics of theophylline administered as a controlled-release tablet.
    Thielemann AM; Manquez N; Pinilla E; Gai MN; Romero P; Arancibia A; Chavez H
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):130-3. PubMed ID: 8705090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Posture and circadian variations in serum theophylline concentrations].
    Kishida M; Hukushima K; Iikura Y
    Arerugi; 1990 Oct; 39(10):1422-6. PubMed ID: 2260930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a short course of prednisolone with sustained-release theophylline in the control of nocturnal asthma.
    Chhabra SK
    Indian J Chest Dis Allied Sci; 1995; 37(1):7-14. PubMed ID: 16892732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
    Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of a new sustained-release formulation of theophylline sodium glycerinate in healthy subjects with a new asymmetric dosage regimen.
    Wang P; Qi M; Zhong D; Fang L
    Biomed Chromatogr; 2003 Jan; 17(1):58-61. PubMed ID: 12583008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of once-daily theophylline dose following the morning versus evening administration.
    Trnavská Z; Vondra V; Elis J
    Arzneimittelforschung; 1989 Sep; 39(9):1149-51. PubMed ID: 2590267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosis.
    Jones KM; Liao E; Hohneker K; Turpin S; Henry MM; Selinger K; Hsyu PH; Boucher RC; Knowles MR; Dukes GE
    Pharmacotherapy; 1997; 17(2):263-70. PubMed ID: 9085317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of theophylline and circadian rhythm].
    Pradalier A; Dry J; Flouvat B; Decourt S; Fodor F
    Pathol Biol (Paris); 1982 Dec; 30(10):851-4. PubMed ID: 6760063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intersubject variability of serum theophylline concentration after single dose of uncoated controlled release theophylline tablet administration in asthmatic patients.
    Raj NS; Guleria R; Misra A; Pande JN
    Indian J Chest Dis Allied Sci; 1997; 39(3):143-7. PubMed ID: 9357147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of sustained-released theophylline on peak expiratory flow rate in asthmatic patients].
    Yoshimine F; Sasagawa M; Kon Y; Yamaguchi S; Suzuki E; Gejyo F
    Arerugi; 2000 Jul; 49(7):593-9. PubMed ID: 10944826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state pharmacokinetics of a once-daily theophylline formulation (Euphylong) when given twice daily.
    Götz J; Sauter R; Steinijans VW; Jonkman JH
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):168-73. PubMed ID: 8032575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theophylline inhibits the late asthmatic response to nighttime antigen challenge in patients with mild atopic asthma.
    Jarjour NN; Lacouture PG; Busse WW
    Ann Allergy Asthma Immunol; 1998 Sep; 81(3):231-6. PubMed ID: 9759799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.